NEW YORK (GenomeWeb) — Cancer diagnostics firm Precipio said today that it expects to report a 213 percent increase in its second quarter revenues on strong demand for its pathology services.

On a preliminary basis, Precipio's revenues for the three-month period ended June 30 were $815,000 compared with $260,000 in the year-ago quarter. The firm said sales of its pathology services were the primary driver of the increase, in part reflecting the effect of its recently expanded sales team.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.